Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Aviezer currently holds 418,000 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Aviezer has been a net seller of PLX stock. They have purchased $0 and sold $6.2M worth of shares.
David Aviezer's most recent insider trade was on Jul 16, 2012, when they sold 418,000 shares at $0.00 per share.
David Aviezer serves as Executive at Protalix BioTherapeutics, Inc. (PLX). They have executed 24 insider transactions totaling $6.2M over their tenure at the company.
David Aviezer holds the position of Executive at Protalix BioTherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
David Aviezer has shown a selling trading pattern, with $0 in total purchases and $6.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Aviezer was on May 2, 2012, when they sold $3.2M worth of PLX shares. This transaction involved 450,000 shares at $7.13 per share.
David Aviezer currently owns 418,000 shares of Protalix BioTherapeutics, Inc. (PLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Aviezer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Aviezer has 24 Form 4 filings on record as an insider at Protalix BioTherapeutics, Inc..
Set alerts for David Aviezer and 40,000+ other insiders.